Indian shares flat after Monday's losses; Ranbaxy leads gainers

Indian shares were little changed but in the negative early Tuesday, after a more than 3 percent decline in the previous session, as Asian markets traded weak after the slight overnight gain on Wall Street.

At 1015 am local time, the 30-share Sensex of the Bombay Stock Exchange was 30.07 points or 0.2 percent down at 15,036.03 while the National Stock Exchange's 50-share S&P CNX Nifty pared half a percent to trade at 4,477.35 points.

Among frontline stocks, there were 19 declines and 11 advances. India's second biggest private bank HDFC Bank Ltd. fell 44 rupees, or 3.72 percent, to 1,183.70.

Tata Consultancy Services Ltd., the country's biggest software exporter, declined 1.56 percent to 915.65 rupees and consumer goods major Hindustan Unilever Ltd. retreated 1.49 percent to 231.95 rupees.

Leading private lender ICICI Bank Ltd. receded 1.02 percent to trade at 750.10 rupees and the country's biggest carmaker Maruti Suzuki India Ltd. declined 0.94 percent to 735.90.

Drugmaker Ranbaxy Laboratories Ltd. led the gainers, and was slightly more than 5 percent up at 526.40 rupees. It was followed by majority state-owned power equipment maker Bharat Heavy Electricals Ltd. (BHEL), which gained about 44 rupees, or 3.23 percent, to 1,374.65.

India's biggest listed company Reliance Industries Ltd. edged up 1.25 percent to 2,163.10 rupees while DLF Ltd., the country's biggest property developer, advanced 1.18 percent to 481.55.

Among the 13 BSE sector indices, six advanced and seven declined. The healthcare gauge was the top gainer, up 1.81 percent, driven mainly by Ranbaxy which weighs in at about 16 percent of the index. The consumer goods sector was the most sold, and traded 1.13 percent lower.

In the broader market, gainers outnumbered losers 788 to 649 on a volume of 41.6 million shares.

Tata Communications Ltd. was the top loser among the Nifty 50, declining 3.59 percent to 456.65 rupees, while Ranbaxy, up 5.38 percent at 554.15 rupees, led gainers.

No comments: